Cargando…
Designing and Synthesis of New Isatin Derivatives as Potential CDK2 Inhibitors
Tumors are still one of the main causes of death; therefore, the search for new therapeutic agents that will enable the implementation of effective treatment is a significant challenge for modern pharmacy. One of the important factors contributing to the development of neoplastic diseases is the ove...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316372/ https://www.ncbi.nlm.nih.gov/pubmed/35887396 http://dx.doi.org/10.3390/ijms23148046 |